Stedham Adam H

CEO Adam Stedham buys 95,000 shares in two tranches ($0.71, $0.68) totaling $66,330, increasing holdings 34.9%; stock down 46.5% in 30 days.

Stedham made 2 separate purchases totaling 95,000 shares for $66,330.00 at $0.71 and $0.68, expanding his holdings from 272,348 to 367,348 shares (+34.9% increase). This transaction arrives after severe near-term price deterioration: the stock is trading at $0.69 (current price), down 46.5% over 30 days and -84.0% from its 52-week high of $4.30. However, his same-ticker purchase history at VRME shows strong timing: his 2 prior buys with measurable 90-day outcomes both delivered +54.0% and +50.3% respective returns, and 2 of 2 prior VRME buys proved well-timed at the 90-day mark. Fundamentally, the company is struggling—unprofitable with net income of $-2.4M against $5.4M quarterly revenue and a $7.2M market cap—yet revenue grew +29.3% year-over-year, suggesting operational momentum beneath current market distress. The divergence between recent price action and his demonstrated track record of well-timed accumulation at this specific ticker warrants attention to underlying business recovery signals that may not yet be reflected in equity pricing.

CEO Stedham purchases 22,000 VRME shares at $0.71; 5th consecutive buy in 12 days amid -65.0% decline from 52-week high

Adam H Stedham, CEO and President, purchased 22,000 shares at $0.71 on 2024-12-30, increasing his holdings to 267,004 shares (a 9.0% increase). This transaction is the 5th open-market buy by the same insider in 12 calendar days (December 3, 4, 5, 16, and 17 preceding this purchase, plus this one on December 30), showing a sustained pattern of accumulation at depressed levels. The stock trades at $0.79 currently, down 65.0% from its 52-week high of $2.26, and has declined 41.9% over the past 90 days despite a modest 1.2% recovery in the past 30 days. While the insider's cross-ticker track record shows a 76.92% 90-day win rate and an average 90-day return of +11.8%, outcomes at this specific ticker are not yet measurable (all 5 prior VRME purchases remain within 30 days of filing). The company generated $5.4M revenue last quarter with a net loss of $2.4M and is unprofitable on a full-year basis, though annual revenue growth reached 29.3%, suggesting operational challenges despite top-line momentum.

CEO Adam Stedham bought 16,000 shares ($9.6K) in two tranches over 2 days at average $0.60; stock down 73% from 52-week high.

CEO and President Stedham made two separate purchases totaling 16,000 shares for $9,560.00 on consecutive days (6,000 shares at $0.61 on 2024-12-16 and 10,000 shares at $0.59 on 2024-12-17), expanding his position by 7.0% to 245,004 shares. The purchases occurred as the stock trades at $0.61 current price, down 73.0% from its 52-week high of $2.26 and down 39.0% over the past 30 days. The company generated $5,435,000 revenue in the latest quarter but posted a net loss of $2,424,000 and remains unprofitable on a full-year basis, despite annual revenue growth of 29.3%. Stedham's cross-ticker buy track record shows an 80.00% 90-day win rate with an average 90-day return of +11.2%, but his prior trades at VerifyMe have generated poor recent results—his most measurable same-ticker buy (2024-11-13) yielded a 30-day return of -33.6%—and 0 of his 0 prior same-ticker buys were well-timed at the 90-day mark. This accumulation in a depressed, unprofitable stock with weak recent same-ticker performance warrants investor attention.

CEO Stedham bought 8,000 shares across 2 transactions for $4,900.00 ($0.60–$0.62) as stock down 46.3% in 30 days from $0.65 current price

Stedham Adam H, CEO and President, executed 2 separate purchases totaling 8,000 shares for $4,900.00 at prices of $0.60 and $0.62 on 2024-12-04 and 2024-12-05, raising his holdings from 221.0K to 229.0K shares (+3.6%). The purchases occur while the stock trades at $0.65, down 46.3% over the prior 30 days and 71.2% from its 52-week high of $2.26. Stedham's prior trades at VRME show positive outcomes: two measurable historical buys (2023-12-22 and 2023-12-26) both delivered 30d returns of +1.9% and +5.8%, and 90d returns of +26.9% and +34.6%, establishing a 2-of-2 well-timed pattern at this ticker. However, the company remains unprofitable (full-year net income of $-2.4M), though it reported revenue of $5.4M in the latest quarter with annual growth of +29.3%. The rapid price decline combined with the CEO's continued accumulation in a loss-making business—despite positive historical timing outcomes at this same ticker—presents a mixed signal requiring deeper examination of catalysts and near-term fundamentals.

CEO Adam H Stedham bought 11,000 shares (11.0K shares) at $0.63 blended average on 2024-12-02/03, extending prior buy pattern at distressed valuation

Stedham executed 2 separate purchases totaling 11,000 shares for $6,900.00 at $0.66 and $0.60, expanding his holdings by 5.2% to 221,004 shares post-transaction. This buy occurs as VRME trades at $0.60 current price, down -73.4% from its 52-week high of $2.26 and off -54.4% over the prior 30 days. The company reported $5.4M in latest quarterly revenue (with +29.3% annual growth) but posted $-2.4M in net income, reflecting ongoing unprofitability. Notably, Stedham has executed 5 prior buys at VRME since 2023-11-28, with his prior 4 completed trades showing a 90-day win rate of 100% (returns of +20.4%, +27.4%, +26.9%, and +34.6%), establishing a consistent pattern of well-timed entry timing at this ticker. The current purchase at a price 10% below the 52-week low extends this accumulation pattern despite the stock's sharp recent decline and the company's negative earnings profile.

CEO Stedham buys 2,000 shares at $0.95, extending pattern of 5 prior buys all well-timed at 90-day mark—but stock down 24.6% in 30d, company unprofitable.

Adam H. Stedham, CEO and President, purchased 2,000 shares of VRME at $0.95 on 2024-11-13, raising his holdings to 210,004 shares. Notably, his prior 5 trades at this ticker show a perfect timing pattern: all 5 buys delivered positive 90-day returns (ranging from +20.0% to +34.6%), indicating sharp execution in identifying value windows. However, the current context is materially weaker: the stock has fallen 24.6% in the past 30 days and stands 56.6% below its 52-week high of $2.26, while the company remains unprofitable with net income of $-2.4M against quarterly revenue of $5.4M. This buy arrives amid significant price deterioration, and whether it extends the insider's track record of well-timed entry points depends on recovery from the recent decline rather than a new value discovery.